This grant is for advancing Parkinson’s Disease (PD) research by forming new, transdisciplinary consortia. The National Institute of Neurological Disorders and Stroke (NINDS) offers Exploratory Grants (P20) to initiate collaborative activities. The goal is to resolve essential PD challenges by building exemplary multi-institutional consortia, gathering preliminary data, and removing critical impediments to understanding and treating PD. This FOA exclusively supports new collaborations, not existing projects. Consortia must include world-class experts, anchored by a PD researcher and integrating complementary expertise. Teams should provide visionary scientific leadership, pursuing goal-driven approaches for PD etiology, pathogenesis, or treatment, fostering innovative research and cutting-edge methodologies.
Opportunity ID: 328114
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-NS-21-002 |
Funding Opportunity Title: | NINDS Morris K. Udall Parkinson’s Disease Research Center Without Walls (P20 Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 4 |
Assistance Listings: | 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Jul 15, 2020 |
Last Updated Date: | Jul 15, 2020 |
Original Closing Date for Applications: | Sep 28, 2020 |
Current Closing Date for Applications: | Sep 28, 2020 |
Archive Date: | Nov 03, 2020 |
Estimated Total Program Funding: | $1,200,000 |
Award Ceiling: | $300,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | State governments Native American tribal governments (Federally recognized) Special district governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education City or township governments Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses County governments Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education Independent school districts |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This Funding Opportunity Announcement (FOA) requests Exploratory Grant (P20) applications for the planning and initiation of collaborative activities to advance Parkinson’s Disease (PD) research. The goal of this FOA is to convene new transdisciplinary research consortia and formalize the multi-institutional organizational and investigational structure necessary to resolve an essential challenge in Parkinson’s disease (PD) through a subsequent NINDS Udall Center without Walls (CWOW) approach. The most compelling applications will: (i) identify a fundamental PD research priority; (ii) build an exemplary research consortium; (iii) gather supportive preliminary data; and (iv) demonstrate exceptional potential to pursue a targeted strategy to remove a critical impediment blocking advancement of the understanding and treatment of PD. The stated challenge and related research feasibility projects will inform the etiology, pathogenesis or treatment of PD; investigations on related synucleinopathies may be included if such studies directly address the central PD research challenge. To foster the development of innovative research collaborations, this FOA will provide support for new research consortia only; continuation of established projects and teams will not be supported. Proposed consortia must include the optimal combination of specialized expertise required to resolve the stated challenge using a goal-driven approach. The Program Director/Principal Investigator (PD/PI) must be eminently qualified to provide visionary scientific leadership and effective oversight of consortium administrative activities. Participating investigators should be recognized as world-class experts in their fields. Teams must be anchored by at least one PD researcher. To maximize potential for new insights and incorporation of cutting-edge approaches, consortia will actively integrate at least one investigator with primary expertise in another, complementary research area. The applicant inst |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-002.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-F | Use for due dates on or after May 25, 2020 | PKG00262587 | Aug 28, 2020 | Sep 28, 2020 | View |
Package 1
Mandatory forms
328114 RR_SF424_2_0-2.0.pdf
328114 PHS398_CoverPageSupplement_5_0-5.0.pdf
328114 RR_OtherProjectInfo_1_4-1.4.pdf
328114 PerformanceSite_2_0-2.0.pdf
328114 RR_KeyPersonExpanded_2_0-2.0.pdf
328114 PHS398_ResearchPlan_4_0-4.0.pdf
328114 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
328114 PHS_Additional_IndirectCosts-1.0.pdf
328114 PHS_AssignmentRequestForm_3_0-3.0.pdf